Gamithromycin (BA1074): PK/PD Breakthroughs and Experimental
2026-05-25
Explore the advanced pharmacokinetic and pharmacodynamic insights behind Gamithromycin (ML-1709460), revealing how tissue-specific drug exposure transforms respiratory disease research and assay precision. This article uniquely translates cutting-edge evidence into actionable parameters for veterinary and translational scientists.
Strategic EZH2 Inhibition: Translational Leverage with EPZ-6
2026-05-24
Explore how EPZ-6438, a next-generation EZH2 inhibitor, is redefining epigenetic cancer research. This thought-leadership guide provides translational researchers with a mechanistic deep-dive, protocol guidance, and actionable strategies to outmaneuver therapeutic resistance in aggressive cancers—including insights drawn from advanced melanoma models and real-world laboratory scenarios.
Lopinavir (ABT-378): Optimizing HIV and Cross-Pathogen Assay
2026-05-23
Lopinavir (ABT-378) sets a new standard for HIV protease inhibitor research, demonstrating robust potency even under high-serum conditions and against resistant strains. Its validated cross-pathogen activity, including against MERS-CoV, empowers translational antiviral workflows and advanced drug resistance studies.
Structural Basis of HCAR3 Selectivity Revealed by Acifran Co
2026-05-22
This study provides the first high-resolution cryo-EM structures of HCAR3 in complex with several selective agonists, including Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid). The findings clarify the molecular determinants of ligand recognition and selectivity for HCAR3 versus HCAR2, offering a foundation for rational design of metabolic disorder research compounds.
EGTA in Calcium Signaling: Applied Protocols and Troubleshoo
2026-05-22
EGTA (egtaizic acid) delivers unmatched selectivity for calcium chelation, empowering researchers to dissect calcium-driven mechanisms in neurodegeneration and vascular inflammation. Explore protocol innovations, troubleshooting, and strategic application insights leveraging APExBIO’s high-purity EGTA.
Dorsomorphin (Compound C): Precision Tools for Bone and Meta
2026-05-21
Unlock the full potential of Dorsomorphin (Compound C) in bone and metabolic research. Explore unique, evidence-based insights into AMPK and BMP pathway inhibition, with practical guidance for experimental design and a deep dive into the latest findings on Wnt-driven bone formation.
Neuroinflammatory CGRP/SP-Piezo2 Axis Drives Trigeminal Allo
2026-05-21
Liao et al. (2026) identify a Ca2+-dependent neuroinflammatory feedback loop involving CGRP, SP, and Piezo2 in trigeminal nerve root compression-induced mechanical allodynia. This mechanistic insight refines the understanding of trigeminal neuralgia and highlights new molecular targets for modulating tactile hypersensitivity.
BRD4 Inhibition Potentiates Erastin-Induced Ferroptosis via
2026-05-20
This study demonstrates that BRD4 inhibition, including with I-BET-762, broadly sensitizes diverse cancer cell lines to erastin-induced ferroptosis by modulating reactive oxygen species (ROS) and FSP1 expression. The findings clarify the mechanistic interplay between BET inhibition and ferroptosis, offering new avenues for cancer biology research and preclinical model development.
Phenothiazines Boost Macrophage Antibacterial Function via R
2026-05-20
This study demonstrates that phenothiazines, specifically Perphenazine, enhance the antibacterial capacity of macrophages by inducing reactive oxygen species (ROS) production and autophagy pathways. These findings highlight a promising host-directed therapeutic strategy for combating intracellular bacterial infections, particularly in the face of increasing antibiotic resistance.
Sodium Orthovanadate: Precision in Phosphorylation State Pre
2026-05-19
Sodium Orthovanadate (Na3VO4) is a high-purity, reversible phosphatase inhibitor crucial for accurate phosphorylation state preservation in kinase and metabolic research. This article details its experimental workflows, troubleshooting strategies, and how its unique properties—offered by APExBIO—enable advanced signal transduction studies, especially in insulin resistance and energy metabolism.
Ionomycin Calcium Salt: Translating Calcium Signaling to Can
2026-05-19
Explore how ionomycin calcium salt, a potent calcium ionophore, bridges the mechanistic understanding of calcium signaling with actionable strategies for translational oncology. This article integrates recent insights on ribosome biogenesis, apoptosis, and tumor resistance, offering protocol guidance and a roadmap for future research.
Clozapine N-oxide: Precision Chemogenetic Actuation in Neuro
2026-05-18
Clozapine N-oxide (CNO) enables selective, non-invasive neuronal activity modulation via DREADDs, empowering advanced circuit dissection with minimal off-target effects. This article demystifies experimental workflows, troubleshooting, and real-world applications, bridging foundational research with high-impact protocols using CNO from APExBIO.
Ceruletide: Synthetic CCK Analog for Pancreatic Research
2026-05-18
Ceruletide is a synthetic decapeptide analog of cholecystokinin (CCK), widely used for pancreatic function research and modeling of gastrointestinal disorders. Robust evidence supports its use in inducing pancreatic and biliary secretions and in acute pancreatitis models. Its defined solubility, purity, and assay protocols make it a gold standard for digestive physiology studies.
PPM-18 for iNOS Inhibition: Experimental Workflows & Trouble
2026-05-17
PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) is a high-purity, selective iNOS expression inhibitor that enables reproducible inflammation and sepsis assays. This article delivers protocol optimization, troubleshooting, and advanced insights for leveraging PPM-18 in NF-κB pathway research.
Perphenazine: Dopamine D2 Antagonist for Neuropharmacology R
2026-05-16
Perphenazine, a multi-receptor dopamine D2 antagonist, is redefining neuropharmacology and host-pathogen research. Leverage its mitochondria-mediated cell death and host-directed antibacterial effects with optimized protocols for robust, translational results.
466 records 18/32 page Previous Next First page 上5页 1617181920 下5页 Last page